Moexipril
- Generic Name
- Moexipril
- Brand Names
- Univasc
- Drug Type
- Small Molecule
- Chemical Formula
- C27H34N2O7
- CAS Number
- 103775-10-6
- Unique Ingredient Identifier
- WT87C52TJZ
- Background
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.
- Indication
用于治疗高血压。
- Associated Conditions
- Hypertension
- Associated Therapies
- -
Moexipril for Primary Biliary Cirrhosis
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00588302
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath